Genmabs Arzerra slår konkurrerende middel i nye sklerosestudier fra Novartis
Relaterede artikler
Genmab-middel fejler i kræftstudie
For abonnenter
Novartis dropper salg af Genmab-middel uden for USA
For abonnenter
En del af Watch Medier
For abonnenter
For abonnenter
Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.
NyhedsbrevsvilkårFor abonnenter
For abonnenter
For abonnenter
Skilled Process Specialist for managing logistic and production processes in SAP
Principal Bioinformatic Scientist, Antibody Technology
Principal Quality Assurance Professional – Combination Products
Senior Laboratory Technician (Laborant) – Biophysical Protein Characterization
QA Manager GMP
Material Scientist and Coordinator
QA/RA Specialist, Patient Handling Division
QP delegate Biologics, CMC
Business Development Manager
Global Head of Rewards
Quality Engineer for Production
Produktionskemiker
Investor Relations Manager
Head of Quality Assurance
Head of OTC Product Development
Environmental Monitoring Professional
Healthcare Compliance Senior Specialist (Associated Director), Ascendis Pharma
Principal Research Scientist within Biophysical characterisation and pre-formulation
Governmental Public Affairs & Communications Head
Senior Consultant / Project Manager - Life Science (R&D & Clinical)
Senior Legal Counsel
ESG Officer